Binbin Li
-
- RNA modifications and cancer 6
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 6
-
- IL-33, ST2, and ILC Pathways 5
- Invertebrate Immune Response Mechanisms 5
- Molecular Medicine top 10%
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 7
- Respiratory viral infections research 5
-
- Asthma and respiratory diseases 5
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Binbin Li
122 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 125
- Molecular Biology 664
- Cancer Research 141
- Immunology 192
- Molecular Medicine 45
- Epidemiology 254
Countries citing papers authored by Binbin Li
This map shows the geographic impact of Binbin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Li more than expected).
Fields of papers citing papers by Binbin Li
This network shows the impact of papers produced by Binbin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Li. The network helps show where Binbin Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Binbin Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 12 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 9 | |
| 11 | 2022 | 1 | |
| 12 | 2022 | 41 | |
| 13 | 2022 | 6 | |
| 14 | 2021 | 23 | |
| 15 | 2020 | 34 | |
| 16 | 2020 | 17 | |
| 17 | The analysis on prevalence rate and pathogenic factors of mammary gland disease of 20000 healthy check-up women in inner Mongolia | 2013 | 1 |
| 18 | 2013 | 2 | |
| 19 | 2013 | 2 | |
| 20 | 2013 | 6 |
About Binbin Li
Binbin Li is a scholar working on Immunology, Family Practice, Molecular Biology, Cancer Research and Internal Medicine, having authored 133 papers that have together received 1.5k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Liver Disease Diagnosis and Treatment (7 papers), RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers), Respiratory viral infections research (5 papers), Asthma and respiratory diseases (5 papers), IL-33, ST2, and ILC Pathways (5 papers) and Invertebrate Immune Response Mechanisms (5 papers). The work is most often cited by research in Molecular Biology (664 citations), Cancer Research (141 citations), Immunology (192 citations), Molecular Medicine (45 citations) and Epidemiology (254 citations). Binbin Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhiwei He, Guoliang Huang, Jia Sun, Li‐Long Pan, Bin Cao, Lee Niswander, Xiaohua Pan, Fei Hou, Zhi Rong Qian and Xiangning Zhang. Their work appears in journals such as Scientific Reports, BMC Cancer, Fish & Shellfish Immunology, International Journal of Medical Sciences and International Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.